| Company/Division name | OrganaBio, LLC |
| Parent company | OrganaBio, LLC |
| Type of work | Manufacturing |
| Reshoring category: | Reshoring |
| What product(s) and/or service(s) were outsourced domestically? | Manufacturing |
| Year reshoring announced: | 2022 |
| Domestically, the work will be done: | In-house |
| City reshored to: | South Miami |
| State(s) reshored to: | FL |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | cell therapy |
| What domestic positive factors made reshoring more attractive? | Higher productivity, Impact on domestic economy |
